Neutralizing capacity of inhibitors on FVIII is lower for natural FVIII/VWF complex than for isolated FVIII: in vitro comparative study in eleven different therapeutic FVIII concentrates.

Subjects

Subjects :

Antibodies, Neutralizing blood
Coagulants therapeutic use
Drug Combinations
Factor VIII genetics
Factor VIII therapeutic use
Hemophilia A drug therapy
Humans
Recombinant Proteins biosynthesis
Recombinant Proteins immunology
Recombinant Proteins therapeutic use
von Willebrand Factor therapeutic use
Antibodies, Neutralizing immunology
Coagulants immunology
Factor VIII immunology
von Willebrand Factor immunology

Details

Language :

English

ISSN :

1365-2516

Volume :

22

Issue :

4

Database :

MEDLINE

Journal :

Haemophilia : the official journal of the World Federation of Hemophilia

Publication Type :

Report

Accession number :

27354216

Full Text :

https://doi.org/10.1111/hae.12975